LUPUS ERYTHEMATOSUS
Clinical trials for LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lupus Gene-Tweak therapy trial pulled before it began
Disease control TerminatedThis study was designed to test a single infusion of CB-010, a CRISPR-edited immune cell therapy, in people with severe lupus that did not respond to standard treatments. The trial was withdrawn before enrolling any participants, so no results are available. It aimed to check saf…
Matched conditions: LUPUS ERYTHEMATOSUS
Phase: PHASE1 • Sponsor: Caribou Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 03:01 UTC
-
Engineered immune cells take on lupus and vasculitis in early trial
Disease control OngoingThis early-stage study tests a new treatment called SC291 for people with severe lupus or vasculitis that hasn't responded to other therapies. SC291 uses specially designed immune cells from a donor to target and attack faulty immune cells driving the disease. The main goal is to…
Matched conditions: LUPUS ERYTHEMATOSUS
Phase: PHASE1 • Sponsor: Sana Biotechnology • Aim: Disease control
Last updated May 26, 2026 02:56 UTC